The World Health Organization (WHO) has released updated recommendations on HIV clinical management providing new and revised guidance on ...
WHO’s 2025 HIV clinical guidelines simplify and strengthen care by recommending more durable, safer treatment regimens, ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive topline results from the Phase 3 ARTISTRY-2 trial. The double-blind trial evaluated the treatment responses of adults with HIV who are ...
In patients with HIV infection on rifampicin TB therapy, twice-daily bictegravir/emtricitabine/tenofovir alafenamide results ...
At presentation, all children living with HIV younger than five years should be considered as having advanced HIV disease ...
Key goals of EHE include, from 2017 to the end of 2025, reducing new HIV infections and diagnoses by 75%, increasing viral suppression among PWH to 95%, and increasing good or better self-rated health ...
The World Health Organization (WHO) has strongly recommended CD4 testing as the preferred method for identifying advanced HIV disease among people living with HIV, as part of its newly released 2025 ...
The WHO has strongly recommended CD4 testing to identify advanced HIV disease under its 2025 guidelines. Here’s why the test ...
Laparoscopic Versus Open Hemihepatectomy: The ORANGE II PLUS Multicenter Randomized Controlled Trial We used data from the HIV/AIDS Cancer Match Study, a population-based HIV and cancer registry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback